PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Clinical trials for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear
Sign up with your email to follow new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new drug trial for kids with tough cancers
Disease control Recruiting nowThis study tests a drug called TURALIO (pexidartinib) in people aged 3 to 35 whose cancer has not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors or control leukemia. Participants take the drug daily for up to 2 years and are clos…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:41 UTC
-
New combo therapy aims to improve leukemia remission with fewer side effects
Disease control Recruiting nowThis study tests a combination of low-dose chemotherapy and immune-targeted drugs in adults newly diagnosed with a specific type of leukemia (Ph-negative B-cell ALL). The goal is to see if this gentler approach can achieve deep remission (no cancer cells detectable) and improve s…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 01, 2026 15:39 UTC
-
New hope for young leukemia patients: CART cell therapy trial launches
Disease control Recruiting nowThis early-stage trial tests whether a new type of CART cell therapy is safe and possible for children, teens, and young adults with leukemia that has come back or not responded to standard treatments. The study involves two different CART cell products tailored to specific leuke…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC